{
    "Orphapacket": {
        "ORPHApacketId": "168999",
        "creationDate": "2023-12-06 11:51:54",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "168999",
        "Label": "Malignant melanoma of the mucosa",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_168999",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare aggressive neoplastic disease characterized by the presence of a melanocyte tumor that develops in any mucosal membrane. Clinical manifestations vary depending on the site of occurrence."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "79386",
                        "Label": "Rare skin tumor or hamartoma"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "22119735[PMID]_RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Lifetime Prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 100 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "Belgium Cancer registry[INST]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Belgium"
                }
            },
            {
                "Prevalence": {
                    "Source": "National Cancer Institute[INST]_24272143[PMID]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United States"
                }
            }
        ]
    }
}